- Home
- SAVA vs QH Comparison
SAVA vs QH Comparison
Compare SAVA & QH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAVA
- QH
- Stock Information
- Founded
- SAVA 1998
- QH 2012
- Country
- SAVA United States
- QH China
- Employees
- SAVA N/A
- QH N/A
- Industry
- SAVA Biotechnology: Pharmaceutical Preparations
- QH Business Services
- Sector
- SAVA Health Care
- QH Consumer Discretionary
- Exchange
- SAVA Nasdaq
- QH Nasdaq
- Market Cap
- SAVA 102.4M
- QH 115.7M
- IPO Year
- SAVA N/A
- QH 2020
- Fundamental
- Price
- SAVA $2.34
- QH $0.11
- Analyst Decision
- SAVA Hold
- QH
- Analyst Count
- SAVA 1
- QH 0
- Target Price
- SAVA $2.00
- QH N/A
- AVG Volume (30 Days)
- SAVA 867.7K
- QH 20.0M
- Earning Date
- SAVA 08-14-2025
- QH 08-27-2025
- Dividend Yield
- SAVA N/A
- QH N/A
- EPS Growth
- SAVA N/A
- QH N/A
- EPS
- SAVA N/A
- QH 0.01
- Revenue
- SAVA N/A
- QH $417,431,053.00
- Revenue This Year
- SAVA N/A
- QH N/A
- Revenue Next Year
- SAVA N/A
- QH N/A
- P/E Ratio
- SAVA N/A
- QH $12.66
- Revenue Growth
- SAVA N/A
- QH N/A
- 52 Week Low
- SAVA $1.15
- QH $0.09
- 52 Week High
- SAVA $33.98
- QH $2.27
- Technical
- Relative Strength Index (RSI)
- SAVA 54.06
- QH 22.51
- Support Level
- SAVA $2.20
- QH $0.09
- Resistance Level
- SAVA $2.43
- QH $0.12
- Average True Range (ATR)
- SAVA 0.17
- QH 0.02
- MACD
- SAVA -0.00
- QH -0.00
- Stochastic Oscillator
- SAVA 60.42
- QH 46.38
About SAVA Cassava Sciences Inc.
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.
About QH Quhuo Limited American Depository Shares
Quhuo Ltd is a gig economy platform focusing on local life services in China. It provide tech-enabled, end-to-end operational solutions to consumer service businesses, including on-demand delivery solutions, mobility service solutions, housekeeping and accommodation solutions, and other services. Its three operating segments, include (i) on-demand delivery solutions, (ii) mobility service solutions, and (iii) housekeeping and accommodation solutions and other services.